yttrium has been researched along with Cancer of Pancreas in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, AY; Pishvaian, MJ; Unger, K; Wang, H | 1 |
| Carter, D; Coldwell, D; Dezarn, WA; Jones, B; Kennedy, AS; Liu, D; McNeillie, P; Murthy, R; Nutting, C; Overton, C; Palmedo, H; Rose, S; Salem, R; Warner, RR | 1 |
| Bernard, BF; Breeman, WA; de Jong, M; Krenning, EP; Valkema, R | 1 |
3 other study(ies) available for yttrium and Cancer of Pancreas
| Article | Year |
|---|---|
Incorporating Yttrium-90 trans-arterial radioembolization (TARE) in the treatment of metastatic pancreatic adenocarcioma: a single center experience.
Topics: Aged; Carcinoma, Pancreatic Ductal; Catheter Ablation; Female; Humans; Liver Neoplasms; Male; Middle Aged; Pancreatic Ducts; Pancreatic Neoplasms; Retrospective Studies; Treatment Outcome; Yttrium; Yttrium Radioisotopes | 2016 |
Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoid Tumor; Embolization, Therapeutic; Female; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Pancreatic Neoplasms; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Survival Rate; Yttrium | 2008 |
Combination radionuclide therapy using 177Lu- and 90Y-labeled somatostatin analogs.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Humans; Lutetium; Male; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Rats; Rats, Inbred Lew; Somatostatin; Survival Analysis; Treatment Outcome; Yttrium | 2005 |